Bloomberg Businessweek cover image

Ozempic’s Success Is Bad News for Rivals

Bloomberg Businessweek

00:00

Introduction

This chapter of the podcast delves into the success of O'Zepic, a drug known for its effectiveness in treating diabetes and weight loss. It discusses the possibility of the drug having positive effects on other health conditions such as kidney disease, heart disease, Alzheimer's, and alcohol use disorder, and the potential repercussions for rival healthcare companies in the market.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app